https://www.selleckchem.com/products/gw-4064.html
PURPOSE Baroreflex activation therapy (BAT) has been shown to lower blood pressure in patients with resistant hypertension. The purpose of this study was to analyze whether this translates into a reduction of more relevant clinical endpoints. METHODS Patients with resistant hypertension were treated with the second-generation BAT system. Records on hospitalization (dates of admission and discharge, main diagnosis) were obtained from medical insurance companies. RESULTS Records on hospitalization were available for a period of 1 year bef
Curtir
Comentario
Compartilhar
